{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:45:20Z","timestamp":1785818720320,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jhin.2023.07.009","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T02:17:03Z","timestamp":1690337823000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cumulative steroid dose in hospitalized patients and COVID-19-associated pulmonary aspergillosis"],"prefix":"10.1016","volume":"142","author":[{"given":"D.","family":"Ramonfaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.","family":"Salto-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Aguirre-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.","family":"Hern\u00e1ndez-Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Villanueva-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Torre-Amione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Mart\u00ednez-Res\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2023.07.009_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.jhin.2023.07.009_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhin.2023.07.009_bib3","doi-asserted-by":"crossref","first-page":"n84","DOI":"10.1136\/bmj.n84","article-title":"Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial","volume":"372","author":"Viega","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jhin.2023.07.009_bib4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhin.2023.07.009_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101489","article-title":"Baricitinib in hospitalised patients with COVID-19: a meta-analysis of randomised controlled trials","volume":"49","author":"Selvaraj","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jhin.2023.07.009_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00134-021-06573-1","article-title":"Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial","volume":"48","author":"Granholm","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhin.2023.07.009_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jhin.2023.07.009_bib9","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.1080\/13693780802227159","article-title":"Invasive aspergillosis in glucocorticoid-treated patients","volume":"47","author":"Lewis","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.jhin.2023.07.009_bib10","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhin.2023.07.009_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13054-022-03902-8","article-title":"Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients","volume":"26","author":"Leistner","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.jhin.2023.07.009_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/myc.13434","article-title":"COVID-19-associated pulmonary aspergillosis (CAPA): risk factors and development of a predictive\u00a0score for critically ill COVID-19 patients","volume":"65","author":"Calder\u00f3n-Parra","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.jhin.2023.07.009_bib13","doi-asserted-by":"crossref","first-page":"jiab163","DOI":"10.1093\/infdis\/jiab163","article-title":"Navigating the uncertainties of COVID-19-associated Aspergillosis: a comparison with influenza-associated Aspergillosis","volume":"224","author":"Lamoth","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhin.2023.07.009_bib14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1001\/jama.2021.18295","article-title":"Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 Randomized Trial","volume":"326","author":"The COVID STEROID 2 Trial Group","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jhin.2023.07.009_bib15","doi-asserted-by":"crossref","first-page":"i969","DOI":"10.1136\/bmj.i969","article-title":"Analysis of matched case-control studies","volume":"352","author":"Pearce","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jhin.2023.07.009_bib16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmi.2022.01.027","article-title":"Defining COVID-19\u2013associated pulmonary aspergillosis: systematic review and meta-analysis","volume":"28","author":"Kariyawasam","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2023.07.009_bib17","first-page":"583","article-title":"Fungal infections in the ICU during the\u00a0COVID-19 pandemic in Mexico","volume":"9","author":"Roman-Montes","year":"2023","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.jhin.2023.07.009_bib18","doi-asserted-by":"crossref","first-page":"ofad062","DOI":"10.1093\/ofid\/ofad062","article-title":"Risk of coronavirus disease 2019\u2013associated pulmonary Aspergillosis based on corticosteroid duration in\u00a0intensive care patients","volume":"10","author":"Shah","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhin.2023.07.009_bib19","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/iid3.517","article-title":"Ferritin level: A predictor of severity and mortality in hospitalized COVID-19 patients","volume":"9","author":"Alroomi","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jhin.2023.07.009_bib20","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/23744235.2022.2101691","article-title":"Early increase of serum ferritin among COVID-19 patients is associated with need of invasive mechanical ventilation and with in-hospital death","volume":"54","author":"Ramonfaur","year":"2022","journal-title":"Infect Dis (Lond)."},{"key":"10.1016\/j.jhin.2023.07.009_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients \u2013 a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2023.07.009_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.4A1015-483R","article-title":"JAK\/STAT regulation of Aspergillus fumigatus corneal infections and IL-6\/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity","volume":"100","author":"Taylor","year":"2016","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jhin.2023.07.009_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/myc.13328","article-title":"Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"64","author":"Singh","year":"2021","journal-title":"Mycoses"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670123002335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670123002335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:22:44Z","timestamp":1759292564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670123002335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":22,"alternative-id":["S0195670123002335"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2023.07.009","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cumulative steroid dose in hospitalized patients and COVID-19-associated pulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2023.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}